Mersana Therapeutics, Inc. Contracts & Agreements

82 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Loan and Security Agreement, dated February 17, 2022, between Oxford Finance LLC, the Lenders named therein including Silicon Valley Bank, and the Company
Loan Agreements
Mersana Therapeutics, Inc.
Biotechnology
NY
2022
Exchange Agreement, dated as of December 19, 2024, by and among Mersana Therapeutics, Inc. and the holders of the common stock listed on Schedule I attached thereto
Exchange Agreements
Mersana Therapeutics, Inc.
Biotechnology
2024
Form of Pre-Funded Warrants
Mersana Therapeutics, Inc.
Biotechnology
2024
Sales Agreement, dated February 28, 2024, by and between the Company and Cowen and Company, LLC
Sales Agreements
Mersana Therapeutics, Inc.
2024
Non-Employee Director Compensation Policy
Compensation Agreements
Mersana Therapeutics, Inc.
2024
Offer Letter, dated
Mersana Therapeutics, Inc.
2024
Amendment No. 1 to the Research Collaboration and License Agreement (effective February 2, 2022), dated July 14, 2023, by and between Mersana Therapeutics, Inc. and Janssen...
Collaboration Agreements
Mersana Therapeutics, Inc.
2023
Amendment No
Mersana Therapeutics, Inc.
2023
Retirement and Separation Agreement, dated S
Separation Agreements
Mersana Therapeutics, Inc.
2023
Offer Letter, dated September 5, 2023, by and between Mersana Therapeutics, Inc. and Martin Huber
Mersana Therapeutics, Inc.
2023
Letter Agreement
Mersana Therapeutics, Inc.
2023
Form of Restricted Stock Unit Agreement under
Stock Agreements
Mersana Therapeutics, Inc.
2023
Form of Restricted Stock Unit Agreement for Employees under the
Stock Agreements
Mersana Therapeutics, Inc.
2023
Form of Restricted Stock Unit Agreement for Non-Employee Directors under the Mersana Therapeutics, Inc. 2017 Stock Incentive Plan
Bonus & Incentive Agreements
Mersana Therapeutics, Inc.
2023
Amendment 2 to the Collaboration and Commercial License Agreement, dated August 12, 2016, by and between Mersana Therapeutics, Inc. and Merck KGaA
Collaboration Agreements
Mersana Therapeutics, Inc.
2023
Amendment 3 to the Collaboration and Commercial License Agreement, dated February 28, 2017, by and between Mersana Therapeutics, Inc. and Merck KGaA
Collaboration Agreements
Mersana Therapeutics, Inc.
2023
License, Development and Commercialization Agreement, dated July 9, 2015, by and between Mersana Therapeutics, Inc. and Recepta Biopharma S.A
License Agreements
Mersana Therapeutics, Inc.
2023
Agreement Regarding LICR Technology, dated July 9, 2015, by and between Ludwig Institute for Cancer Research, Recepta Biopharma S.A. and Mersana Therapeutics, Inc
Mersana Therapeutics, Inc.
2023
Amendment 1 to the Collaboration and Commercial License Agreement, dated June 1, 2016, by and between Mersana Therapeutics, Inc. and Merck KGaA
Collaboration Agreements
Mersana Therapeutics, Inc.
2023
Collaboration and Commercial License Agreement, dated June 23, 2014, by and between Mersana Therapeutics, Inc. and Merck KGaA
Collaboration Agreements
Mersana Therapeutics, Inc.
2023
Fourth Amendment to Loan and Security Agreement, dated March 23, 2023, between Oxford Finance LLC, the Lenders named therein including Silicon Valley Bridge Bank, N.A., and...
Loan Agreements
Mersana Therapeutics, Inc.
2023
Non-Employee Director Compensation Policy, effective as of December 1, 2022
Compensation Agreements
Mersana Therapeutics, Inc.
Biotechnology
2023
2017 Employee Stock Purchase Plan
Stock Agreements
Mersana Therapeutics, Inc.
Biotechnology
DE
2023
Third Amendment to Loan and Security Agreement, dated December 27, 2022, between Oxford Finance LLC, the Lenders named therein including Silicon Valley Bank, and Mersana...
Loan Agreements
Mersana Therapeutics, Inc.
2023
Second Amendment to Loan and Security Agreement, dated October 17, 2022, between Oxford Finance LLC, the Lenders named therein including Silicon Valley Bank, and Mersana...
Loan Agreements
Mersana Therapeutics, Inc.
2023
Collaboration and Commercial License Agreement, dated December 22, 2022, between Mersana Therapeutics, Inc. and Ares Trading S.A
Collaboration Agreements
Mersana Therapeutics, Inc.
Biotechnology
DE
2023
Description of Securities
Mersana Therapeutics, Inc.
Biotechnology
2023
Sales Agreement dated November 7, 2022 by and between the Company and Cowen and Company, LLC
Sales Agreements
Mersana Therapeutics, Inc.
2022
Research Collaboration and License Agreement, dated February 2, 2022, between the Company and Janssen Biotech, Inc
Collaboration Agreements
Mersana Therapeutics, Inc.
2022
Amendment No. 1 to the Amended and Restated Commercial License and Option Agreement, dated February 2, 2022, between the Company and Synaffix B.V
License Agreements
Mersana Therapeutics, Inc.
2022
Offer Letter, dated March 5, 2021, between the Company and Alejandra Carvajal
Mersana Therapeutics, Inc.
Biotechnology
2022
Offer Letter, dated June 15, 2021, between the Company and Tushar Misra
Mersana Therapeutics, Inc.
Biotechnology
2022
Loan and Security Agreement, dated October 29, 2021, by and between Oxford Finance LLC, Silicon Valley Bank and Mersana Therapeutics, Inc
Loan Agreements
Mersana Therapeutics, Inc.
2022
Sales Agreement dated February 28, 2022 by and between the Company and Cowen and Company, LLC
Sales Agreements
Mersana Therapeutics, Inc.
Biotechnology
NY
2022
Form of Non-statutory Stock Option under the 2022 Inducement Stock Incentive Plan
Bonus & Incentive Agreements
Mersana Therapeutics, Inc.
2022
Form of Inducement Restricted Stock
Stock Agreements
Mersana Therapeutics, Inc.
Biotechnology
2022
2022 Inducement Stock Incentive Plan
Bonus & Incentive Agreements
Mersana Therapeutics, Inc.
Biotechnology
DE
2022
Amended and Restated Commercial License and Option Agreement, dated November 23, 2021, by and between Synaffix B.V. and Mersana Therapeutics, Inc
License Agreements
Mersana Therapeutics, Inc.
2022
Second Amendment to the License, Development and Commercialization Agreement, dated September 28, 2021, by and between Mersana Therapeutics, Inc. and Recepta Biopharma S.A....
License Agreements
Mersana Therapeutics, Inc.
Biotechnology
2021
Form of Restricted Stock Unit under the 2017 Stock Incentive Plan
Bonus & Incentive Agreements
Mersana Therapeutics, Inc.
Biotechnology
2021
Amended and Restated Offer Letter, by and between Mersana Therapeutics, Inc. and Michael Kaufman, dated March 8, 2017
Mersana Therapeutics, Inc.
2021
Offer Letter, by and between Mersana Therapeutics, Inc. and Arvin Yang, dated November 5, 2020
Mersana Therapeutics, Inc.
Biotechnology
2021
Eighth Lease Modification Agreement to the Lease Between Rivertech Associates II LLC and Mersana Therapeutics, Inc., effective as of April 5, 2021, by and between Mersana...
Lease Agreements
Mersana Therapeutics, Inc.
Biotechnology
2021
Second Amendment to Loan and Security Agreement, dated August 28, 2020, by and between Mersana Therapeutics, Inc, and Silicon Valley Bank
Loan Agreements
Mersana Therapeutics, Inc.
2020
Commercial License and Option Agreement
License Agreements
Mersana Therapeutics, Inc.
Biotechnology
MA
2020
Underwriting Agreement, dated May 28, 2020, among Mersana Therapeutics, Inc. and Cowen and Company, LLC and SVB Leerink LLC, as representatives of the several underwriters listed...
Underwriting Agreements
Mersana Therapeutics, Inc.
2020
Offer Letter, by and between Mersana Therapeutics, Inc. and Dirk Huebner, dated November 5, 2018
Mersana Therapeutics, Inc.
2020
Seventh Lease Extension and Modification Agreement to the Lease Between Rivertech Associates II LLC and Mersana Therapeutics, Inc. dated March 10 2020, by and between Mersana...
Lease Agreements
Mersana Therapeutics, Inc.
Biotechnology
2020
Offer Letter, by and between Mersana Therapeutics, Inc. and Brian DeSchuytner, dated June 10, 2019
Mersana Therapeutics, Inc.
2020
Description of Registrants Common Stock
Stock Agreements
Mersana Therapeutics, Inc.
2020
Exchange Agreement between Mersana Therapeutics, Inc. and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P. and Biotechnology Value Trading Fund OS, L.P., dated...
Exchange Agreements
Mersana Therapeutics, Inc.
2019
Form of Exchange Warrant
Warrant Agreements
Mersana Therapeutics, Inc.
2019
First Amendment to the License, Development and Commercialization Agreement dated August 19, 2019, by and between Mersana Therapeutics, Inc. and Recepta Biopharma, S.A
License Agreements
Mersana Therapeutics, Inc.
Biotechnology
2019
First Amendment to Loan and Security Agreement, dated June 21, 2019, by and between Mersana Therapeutics, Inc. and Silicon Valley Bank
Loan Agreements
Mersana Therapeutics, Inc.
2019
Loan and Security Agreement dated May 8, 2019, by and between Mersana Therapeutics, Inc. and Silicon Valley Bank
Loan Agreements
Mersana Therapeutics, Inc.
2019
Offer Letter, by and between Mersana Therapeutics, Inc. and David Spellman, dated December 18, 2017
Mersana Therapeutics, Inc.
2019
Loan and Security Agreement dated May 8, 2019, by and between Mersana Therapeutics, Inc. and Silicon Valley Bank
Loan Agreements
Mersana Therapeutics, Inc.
Biotechnology
MA
2019
Underwriting Agreement, dated February 28, 2019, by and among Mersana Therapeutics, Inc. and SVB Leerink LLC, as the representative of the several underwriters listed on Schedule...
Underwriting Agreements
Mersana Therapeutics, Inc.
2019
Amendment 4 to Collaboration and Commercial License Agreement dated May 15, 2018, by and between Mersana Therapeutics, Inc. and Merck KGaA
Collaboration Agreements
Mersana Therapeutics, Inc.
Biotechnology
2018
Sixth Lease Extension and Modification Agreement, dated January 17, 2018, by and between Mersana Therapeutics, Inc. and Rivertech Associates II LLC
Lease Agreements
Mersana Therapeutics, Inc.
2018
Third Amendment to Amended and Restated Research Collaboration and Commercial License Agreement, dated October 30, 2017, by and between Mersana Therapeutics, Inc. and Millennium...
Collaboration Agreements
Mersana Therapeutics, Inc.
Biotechnology
2017
SECOND AMENDMENT TO AMENDED AND RESTATED RESEARCH COLLABORATION AND COMMERCIAL LICENSE AGREEMENT
Collaboration Agreements
Mersana Therapeutics, Inc.
Biotechnology
2017
MERSANA THERAPEUTICS, INC. [] Shares of Common Stock, par value $0.0001 per share Underwriting Agreement
Underwriting Agreements
Mersana Therapeutics, Inc.
2017
MERSANA THERAPEUTICS, INC. INDEMNIFICATION AGREEMENT
Indemnification Agreements
Mersana Therapeutics, Inc.
Biotechnology
DE
2017
MERSANA THERAPEUTICS, INC. 2017 STOCK INCENTIVE PLAN
Bonus & Incentive Agreements
Mersana Therapeutics, Inc.
Biotechnology
MA
2017
MERSANA THERAPEUTICS, INC. 2017 STOCK INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT
Bonus & Incentive Agreements
Mersana Therapeutics, Inc.
Biotechnology
2017
MERSANA THERAPEUTICS, INC. 2017 STOCK INCENTIVE PLAN NON-STATUTORY STOCK OPTION AGREEMENT
Bonus & Incentive Agreements
Mersana Therapeutics, Inc.
2017
MERSANA THERAPEUTICS, INC. 2017 EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
Mersana Therapeutics, Inc.
Biotechnology
DE
2017
MERSANA THERAPEUTICS, INC. 2017 CASH BONUS PLAN
Bonus & Incentive Agreements
Mersana Therapeutics, Inc.
Biotechnology
MA
2017
WARRANT TO PURCHASE COMMON STOCK OF MERSANA THERAPEUTICS, INC. (A DELAWARE CORPORATION) SEPTEMBER 27, 2013
Warrant Agreements
Mersana Therapeutics, Inc.
2017
CONFIDENTIAL LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT between MERSANA THERAPEUTICS, INC. and RECEPTA BIOPHARMA S.A.
License Agreements
Mersana Therapeutics, Inc.
2017
MERSANA THERAPEUTICS, INC. THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Mersana Therapeutics, Inc.
2017
INDENTURE OF LEASE by and between RIVERTECH ASSOCIATES II, LLC (LESSOR) and MERSANA THERAPEUTICS, INC. (LESSEE)
Indenture Agreements
Mersana Therapeutics, Inc.
2017
RIVERSIDE TECHNOLOGY CENTER FIFTH LEASE EXTENSION AND MODIFICATION AGREEMENT TO THE LEASE BETWEEN RIVERTECH ASSOCIATES II LLC AND MERSANA THERAPEUTICS, INC.
Lease Agreements
Mersana Therapeutics, Inc.
Biotechnology
2017
CONFIDENTIAL COLLABORATION AND COMMERCIAL LICENSE AGREEMENT between MERSANA THERAPEUTICS, INC. and MERCK KGaA
Collaboration Agreements
Mersana Therapeutics, Inc.
Biotechnology
MA
2017
CONFIDENTIAL AMENDMENT 1 TO COLLABORATION AND COMMERCIAL LICENSE AGREEMENT
Collaboration Agreements
Mersana Therapeutics, Inc.
2017
CONFIDENTIAL AMENDMENT 2 TO COLLABORATION AND COMMERCIAL LICENSE AGREEMENT
Collaboration Agreements
Mersana Therapeutics, Inc.
2017
CONFIDENTIAL AMENDMENT 3 TO COLLABORATION AND COMMERCIAL LICENSE AGREEMENT
Collaboration Agreements
Mersana Therapeutics, Inc.
Biotechnology
2017
CONFIDENTIAL AMENDMENT NUMBER ONE to the COLLABORATION AGREEMENT
Collaboration Agreements
Mersana Therapeutics, Inc.
Biotechnology
MA
2017
CONFIDENTIAL AMENDMENT NUMBER ONE to the COLLABORATION AGREEMENT
Collaboration Agreements
Mersana Therapeutics, Inc.
2017
CONFIDENTIAL COLLABORATION AGREEMENT BY AND BETWEEN ADIMAB, LLC AND MERSANA THERAPEUTICS, INC. JULY 25, 2012 [***] Portions of this exhibit have been redacted pursuant to a...
Collaboration Agreements
Mersana Therapeutics, Inc.
Biotechnology
MA
2017
CONFIDENTIAL
Mersana Therapeutics, Inc.
2017